Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Pathogenesis of beta2-microglobulin amyloidosis.

Ohashi K.

Pathol Int. 2001 Jan;51(1):1-10. Review.

PMID:
11148456
2.

Beta2-microglobulin and amyloidosis.

Drüeke TB.

Nephrol Dial Transplant. 2000;15 Suppl 1:17-24. Review.

PMID:
10737162
3.

Beta2-microglobulin and renal bone disease.

Wada T, Miyata T, Sakai H, Kurokawa K.

Perit Dial Int. 1999;19 Suppl 2:S413-6. Review.

PMID:
10406556
4.

Implication of the glycoxidation and lipoxidation reactions in the pathogenesis of dialysis-related amyloidosis (Review).

Sugiyama S, Miyata T, Inagi R, Kurokawa K.

Int J Mol Med. 1998 Nov;2(5):561-5. Review.

PMID:
9858652
5.

Pathological aspects of beta(2)-microglobulin amyloidosis.

Jadoul M, Garbar C, van Ypersele de Strihou C.

Semin Dial. 2001 Mar-Apr;14(2):86-9. Review.

PMID:
11264772
6.

Pathogenesis of dialysis-related amyloidosis.

Miyata T, Maeda K.

Curr Opin Nephrol Hypertens. 1995 Nov;4(6):493-7. Review.

PMID:
8591057
7.

Dialysis-related amyloidosis: pathogenesis focusing on AGE modification.

Niwa T.

Semin Dial. 2001 Mar-Apr;14(2):123-6. Review.

PMID:
11264780
8.

Fatal cervical spondyloarthropathy in a hemodialysis patient with systemic deposition of beta2-microglobulin amyloid.

Danesh FR, Klinkmann J, Yokoo H, Ivanovich P.

Am J Kidney Dis. 1999 Mar;33(3):563-6. Review.

PMID:
10070922
9.

Extraskeletal problems and amyloid.

Drüeke TB.

Kidney Int Suppl. 1999 Dec;73:S89-93. Review.

PMID:
10633472
10.

'Carbonyl stress' and dialysis-related amyloidosis.

Miyata T, Ueda Y, Saito A, Kurokawa K.

Nephrol Dial Transplant. 2000;15 Suppl 1:25-8. Review.

PMID:
10737163
12.

Molecular interactions in the formation and deposition of beta2-microglobulin-related amyloid fibrils.

Naiki H, Yamamoto S, Hasegawa K, Yamaguchi I, Goto Y, Gejyo F.

Amyloid. 2005 Mar;12(1):15-25. Review.

PMID:
16076607
13.

[Amyloidosis associated with long-term dialysis].

Gejyo F, Maruyama H, Arakawa M.

Nihon Jinzo Gakkai Shi. 1995 Jan;37(1):1-6. Review. Japanese.

PMID:
7699947
14.

Dialysis-related amyloidosis: late finding or hidden epidemic?

Dember LM, Jaber BL.

Semin Dial. 2006 Mar-Apr;19(2):105-9. Review.

PMID:
16551286
15.

The pathogenesis of beta(2)-microglobulin-induced bone lesions in dialysis-related amyloidosis.

Tran M, Rutecki GW, Sprague SM.

Semin Dial. 2001 Mar-Apr;14(2):131-3. Review.

PMID:
11264782
16.

Systemic distribution of beta 2-microglobulin-derived amyloidosis in patients who undergo long-term hemodialysis. Report of seven cases and review of the literature.

Gal R, Korzets A, Schwartz A, Rath-Wolfson L, Gafter U.

Arch Pathol Lab Med. 1994 Jul;118(7):718-21. Review.

PMID:
8024407
17.

Pathophysiology of advanced glycation end-products in renal failure.

Miyata T, Iida Y, Horie K, Cai Z, Sugiyama S, Maeda K.

Nephrol Dial Transplant. 1996;11 Suppl 5:27-30. Review.

PMID:
9044303
18.

Beta 2-microglobulin amyloidosis: role of monocytes/macrophages.

Hou FF, Owen WF Jr.

Curr Opin Nephrol Hypertens. 2002 Jul;11(4):417-21. Review.

PMID:
12105392
19.

Pathogenesis and management of dialysis-related amyloid bone disease.

Nangaku M, Miyata T, Kurokawa K.

Am J Med Sci. 1999 Jun;317(6):410-5. Review.

PMID:
10372842
20.

Supplemental Content

Support Center